Monomethyl Fumarate Patent Expiration
Monomethyl Fumarate is used for managing symptoms of multiple sclerosis. It was first introduced by Banner Life Sciences Llc
Monomethyl Fumarate Patents
Given below is the list of patents protecting Monomethyl Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bafiertam | US11590095 | Fumarate ester dosage forms | Mar 18, 2036 | Banner Life Sciences |
| Bafiertam | US10945985 | Fumarate ester dosage forms | Aug 14, 2035 | Banner Life Sciences |
| Bafiertam | US10918615 | Fumarate esters | Aug 12, 2035 | Banner Life Sciences |
| Bafiertam | US10918617 | Fumarate ester pharmaceutical compositions | Aug 10, 2035 | Banner Life Sciences |
| Bafiertam | US10918616 | Fumarate ester pharmaceutical compositions | Jun 03, 2035 | Banner Life Sciences |
| Bafiertam | US10098863 | Fumarate esters | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US10105335 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US10105336 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US10105337 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US11903918 | Fumarate ester dosage forms with enhanced gastrointestinal tolerability | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9326947 | Controlled release fumarate esters | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9326965 | Controlled release fumarate esters | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9511043 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9517209 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9566259 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9636318 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9636319 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9814691 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9814692 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9820960 | Fumarate ester pharmaceutical compositions | Feb 27, 2035 | Banner Life Sciences |
| Bafiertam | US9820961 | Fumarate ester dosage forms | Feb 27, 2035 | Banner Life Sciences |
Monomethyl Fumarate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List